Cargando…
Choosing appropriate patient‐reported outcome measures for prostate disease
Autores principales: | Ng, Alexander, Khetrapal, Pramit, Brew‐Graves, Chris, Muirhead, Nicola, Asif, Aqua, Chan, Vinson Wai‐Shun, Nathan, Arjun, Kasivisvanathan, Veeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231676/ https://www.ncbi.nlm.nih.gov/pubmed/35783591 http://dx.doi.org/10.1002/bco2.136 |
Ejemplares similares
-
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023) -
There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022) -
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022) -
Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain
por: Migliorini, Filippo, et al.
Publicado: (2022) -
Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial
por: Gallagher, Kevin, et al.
Publicado: (2023)